Non-Hodgkin Lymphoma Treatment Pipeline Shows below Average Innovation

The product pipeline for Non-Hodgkin Lymphoma (NHL) exhibits a lower degree of innovation than both the industry and oncology average. Just 28% of all pipeline products, or 33% of the pipeline for which there is a disclosed molecular target, are categorized as first-in-class. In comparison, industry, breast cancer and lung cancer exhibit innovation rates of 43%, 57% and 59%, respectively. While NHL, collectively, is the sixth to tenth most common cancer dependent on territory, each individual subtype is classified as an orphan disease. With significant differences in each subtype’s genetic profile and current treatment, there is reduced scope for the development of a targeted therapy with cross-subtype activity. This does not present NHL drug development as an attractive investment in comparison to other indications in oncology, particularly since the survival durations across many NHL subtypes are relatively strong, and likely the reason for low first-in-class innovation levels.

GBI Research’s Frontier Pharma: Innovative Licensing Opportunities in Non-Hodgkin Lymphoma report includes information on the current clinical and commercial landscape, and the composition of the NHL therapeutics market in terms of dominant molecule types and targets, as well as highlighting current unmet needs.

Key highlights from the report:

  • There are 666 marketed products for NHL, 95% of which are small molecules
  • The treatment of lymphoma is dominated by the use of combination cyclophosphamide based chemotherapy in combination with rituximab
  • The variation in molecule type has shifted away from small molecules, whose dominance has decreased to 46% across the pipeline
  • There is a significant shift away from cytotoxic agents, with the current pipeline dominated by cancer immunotherapies and signal transduction inhibitors

Despite the difficulty in achieving improved efficacy rates, the development of such treatments remains of key interest across NHL. Find out more!

A Competitive Assessment of the NPWT Current and Future Players

The global negative pressure wound therapy (NPWT) market is a burgeoning market with numerous players developing innovative technologies. Recent advancements in the field of wound management have greatly expanded the potential of therapeutic applications. Increasing physician and patient awareness of NPWT as well as the rising prevalence of diseases directly associated with the onset of chronic wounds, such as diabetes mellitus and cardiovascular disease, are expected to drive the growth of the global NPWT market.

GlobalData’s Negative Pressure Wound Therapy – Current and Future Players report includes an analysis of company market shares, industry trends, and corporate strategy, identifies the unmet needs in the market while providing an understanding of physicians’ perceptions and decision-making processes in using and evaluating the adoption of different types of NPWT devices.

This report includes:

  • Investigation of current and future market competition for NPWT devices
  • Competitive assessment including device approval analysis
  • Coverage of key market players and company profiles including business description, financial overview, product portfolio assessment, and SWOT analysis
  • Strategic assessment of the market through market impact analysis, future market scenario, and company analysis

With improvements in the design of NPWT devices, they have the potential to become the standard of treatment for acute and chronic wounds in the coming years. Find out how!

Private companies dominate the SBR sector in Taiwan

The Taiwan SBR plant capacity has increased from 0.120 MMTPA in 2005 to 0.150 MMTPA in 2014, at a CAGR of 2.5% and is expected to remain the same at 0.150 MMTPA until 2019. Private companies dominate the SBR sector in Taiwan. The major companies in the region are TSRC Corporation, Chi Mei Corporation. Together these companies have accounted for 100% of the SBR capacity in Taiwan in 2014.

GlobalData’s report Styrene-Butadiene Rubber (SBR) Industry Outlook in Taiwan to 2019 provides historical and forecast market size, demand and production forecasts, end-use demand details, price trends, trade balance data, and company shares of the country’s leading Styrene-Butadiene Rubber producers.

This report includes:

  • Comprehensive information of all planned and active projects in Taiwan
  • Capacity forecasts to 2019 with details of processes, technologies, operators and equities
  • SBR industry market dynamics and supply scenario in from 2005 to 2019
  • Company capacity shares for key Styrene-Butadiene Rubber producers in Taiwan

Are you aware of the macro and microeconomic trends affecting Taiwan’s SBR industry?

Global Gas Generator Market Estimated at $3.7 Billion in 2014

The Global gas generator market was valued at $3.7 billion in 2014, growing from $2 billion in 2006, at a CAGR of 8.1%. The US, Brazil and China were the largest contributors; their combined share accounted for 54% of the market, this will rise further to 2025. Local vendors find it difficult to compete with global giants such as GE Group, CAT Group and Cummins. A favorable factor for these established manufacturers is the complexity of the technology, making gas generators costly products. As a result, small manufacturers struggle to enter the market due to the high capital requirement. Another significant factor being safety concerns, which reduces customer confidence in the local manufacturers.

 

GlobalData’s Gas Generator Market – Global Market Size, Equipment Share and Competitive Analysis to 2025 report gives detailed information on the current market, focusing on key countries, as well as the global scenario. The report analyses annual installations, revenues and share of the various voltage levels for the eight key countries in the market.

This report includes:

  • An in-depth analysis of the US, UK, Germany, China, Brazil, Nigeria, South Africa and India
  • Annual installations and market size for 2006 to 2025
  • Market share of players/leading players in 2014
  • Key drivers and restraints impacting the gas generator market at global and country levels

Find out why local generator vendors are finding it difficult to compete with the global giants such as GE Group, CAT Group and Cummins!

Oman and China Drive Global Storage to Record Capacity

The pipeline of planned oil and chemical storage projects will push global capacity from 5,700 mmbbl in 2015 to almost 6,195 mmbbl by 2019, at growth of 15%. Asia, Middle East and North America will collectively drive new construction of oil and chemical storage terminals, totalling to US$37 billion in capital expenditure. The storage capacity in Asia is set to increase by around 368 mmbbl, amounting to about 50% of global capacity growth by 2019.

Next in-line are Oman and Iran, who also have the most planned oil and chemical storage capacity being built with high capital expenditure over the next five years. Regions such as Europe, Africa and South America are expected to witness relatively low oil and chemical storage capacity additions of 38.6 mmbbl, 29.6 mmbbl and 6.9 mmbbl respectively by 2019.

CNOOC Limited is driving planned storage capacity in China, with the Fujian II terminal in the Fujian region accounting for almost 63 mmbbl. Oman Oil Company, with a planned capacity increase of over 204 mmbbl, will account for the majority of the planned capacity in the Middle East. The Iran Ministry of Petroleum is planning on adding over 21..4 mmbbl by 2019. Fairway Energy Partners, LLC and TransCanada Corporation are the major operators behind the growth, with 10 mmbbl and around 5 mmbbl respectively.

Our latest report Global Capacity and Capital Expenditure Outlook for Oil and Chemical Storage – Oman and China Drive Global Storage to Record Capacity, provides historical oil and chemical storage capacity data by major regions in the world from 2009 to 2014, with forecasts up to 2019. The report also gives details of major planned oil and chemical storage projects in the world up to 2019.

The report includes:

  • Annual breakdown of capital expenditure spending on proposed oil and chemical storage projects for the period 2015 to 2019
  • Planned oil and chemical storage capacity additions and capital expenditure spending by key countries and companies across the world
  • Region wise planned capacity additions and capital expenditure spending of new oil and chemical storage projects by key countries and companies

Report Information
Price: $1,500 (Single User License)
Published: Oct- 2015
Report Format: electronic pdf

Small Wind Turbine Market Dominated By China

In 2008, the US was the largest contributor to global small wind capacity, while China was a close second. By 2014, although the capacity in the US had increased, its market share had reduced as China’s capacity increased significantly. Unlike Europe, China does not have a public sentiment problem with urban wind power, and finds it easier to commercialize the designs due to low-cost manufacturing. It has been more open to implementing the European designs, and their own indigenous innovative designs, at a commercial scale.

China, is the largest manufacturing hub for small turbines, and manufactures turbines of all sizes and designs. Chinese turbines are the cheapest globally, and are exported to many other countries. It manufactures several revolutionary vertical axis designs, including Darrieus, Savonius, Windspire, helical turbines, and Maglev turbines.
European countries have excelled in the R&D of several new and innovative designs of small wind turbines, mostly for integration with urban infrastructure such as buildings, roads and street-lamps. However, they have continued using the traditional designs and have been unenthusiastic about manufacturing and installing the new models. The reason European countries have not adopted the new designs could be due to the negative public sentiment over urban wind power – as most of these designs are meant for urban integration – and also the risk aversion that thwarts commercialization.

GlobalData’s ‘Small Wind Turbine (up to 100kW) Market, Update 2015 – Market Size, Average Price, Competitive Landscape, Regulations and Key Country Analysis to 2025’, report provides a clear overview of and detailed insight into the global small wind turbine market, covering the key countries, namely – US, Canada, UK, Germany, Spain, China, and India.

The report includes:

  • Detailed historic and forecast statistics for cumulative and annual small wind capacity and annual electricity generation from 2008 to 2025, globally and for each of the key countries.
  • Key growth drivers and challenges related to the global small wind turbine market
  • Major manufacturers globally and in each of the key countries

Major policies and regulations affecting and supporting the small wind turbine market in each of the key countries are discussed

Report Information
Price: $3,995 (Single User License)
Published: Nov- 2015
Report Format: electronic pdf

Global Bioabsorbable Scaffolds Market Will Rocket Beyond $2 Billion by 2021

The global market value for bioabsorbable scaffolds (BAS) will expand rapidly from $143.7 million in 2014 to just under $2.1 billion by 2021, driven primarily by new product approvals and a paradigm shift in the clinical treatment of vascular diseases towards minimally-invasive procedures. This significant increase, which will occur across the ten major markets, represents an impressive CAGR of 42.1%. With sufficient improvements, BAS could begin to challenge drug-eluting stents as the gold standard of coronary and peripheral artery disease stenting, as BAS devices aim to directly confront the current issues with permanent metallic stents, such as late in-stent restenosis, vessel scarring and late stent thrombosis. Technological trends in the market are aimed at reducing the thickness of BAS and providing better delivery systems, more efficient drug-elution characteristics, and faster resorption times.

GlobalData’s MediPoint: Bioabsorbable Scaffolds – Global Analysis and Market Forecasts report provides analysis across the ten major markets – the US, UK, France, Germany, Italy, Spain, Japan, Brazil, China and India, including annualised market data from 2014 and forecasts until 2021.

Key questions answered in this report:

  • What is the current and future outlook of bioabsorbable scaffolds in developed and emerging markets?
  • What trends are affecting the global market?
  • What are the market sizes of each segment?
  • What are unmet needs in the market? What are the clinical and non-clinical barriers in this space?
  • What is the physician perceptions and market outlook of bioabsorbable scaffolds which are considered to be the fourth revolution in interventional cardiology?

The expanding presence of BAS products, along with a reduction in their prices, will drive substantial growth by 2021. Find out more!